These emerging therapies , Retatrutide, represent a groundbreaking advancement in treating metabolic dysfunction and potentially other conditions . They are categorized as GLP-1 hormone stimulators, https://rajanxeoa337613.azzablog.com/41974957/semaglutide-a-comprehensive-dive-into-glp-1-compounds